Differential responses to taxanes and PARP inhibitors in ATM‐ versus BRCA2‐mutated metastatic castrate‐resistant prostate cancer
暂无分享，去创建一个
N. Agarwal | E. Antonarakis | C. Sternberg | A. Bryce | A. Alva | O. Sartor | P. Barata | P. Vlachostergios | M. Taplin | R. Aggarwal | R. McKay | Alexandra O. Sokolova | Emily Nizialek | Ryan Ashkar | N. Adra | M. Cieslik | N. Nafissi | N. Sayegh | J. Berchuck | H. McClure | Christopher T Su | Heather H. Cheng